The lawsuit alleges that the approval of Ruzurgi, a rival drug from privately held Jacobus Pharma, violated provisions of FDA regulations and Catalyst’s rights to exclusivity for its drug, Firdapse
Allergan are suing American pharma giant Pfizer over potential damages that they may be forced to pay relating to hundreds of lawsuits that have been filed against them over their alleged role in the opioid crisis.